Interferon-beta in Pediatric Multiple Sclerosis Patients: Safety in Short-Term Prescription

Interferon-beta in Pediatric Multiple Sclerosis Patients: Safety in Short-Term Prescription

Show other versions (1)

None of the approved immunomodulatory drugs in adults Multiple Sclerosis (MS) patients have been officially approved for the pediatric patients and are currently used off-label in this population. In this study, we evaluated the effectiveness and tolerability of intramuscular interferon beta1-a (Avo...

Full description

Bibliographic Details
Main Authors: Keivan Basiri, Masood Etemadifar, Fatemeh Derakhshan, Fereshteh Ashtari, Vahid Shaygannejad, Zahra Fatehi, Amir Hadi Maghzi, Farzad Fatehi
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2012-02-01
Series:Acta Medica Iranica
Subjects:
Multiple Sclerosis
Pediatrics
Childhood
Interferons
Online Access:https://acta.tums.ac.ir/index.php/acta/article/view/3865

Internet

https://acta.tums.ac.ir/index.php/acta/article/view/3865

Similar Items